News & Insights

Precision’s Dana Goldman has been elected to ISPOR’s Board of Directors, effective July 1st, 2015. The Board of Directors are elected by ISPOR members – over 9,500 global members were given the opportunity to vote for nominated candidates.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is the world’s largest professional organization focused on pharmacoeconomics and outcomes research.  Its total membership exceeds 16,500 from 120 countries worldwide.

Analysis from Medicare claims data from Precision’s Research Economist Joanna MacEwan, PhD at the American Diabetes Association 2015 Scientific Sessions.

By Miriam E. Tucker

BOSTON — Among US Medicare beneficiaries with type 2 diabetes, out-of-pocket expenses diminish adherence to medication and may end up increasing overall healthcare costs in the long run, a new study finds.

(more…)

Precision Advisors is cited in a Pharmaceutical Commerce article focusing on access to EHR data.

Recently, Dan Renick, Co-President and Chief Commercial Officer, Precision for Medicine spoke with CEOCFO Magazine on the Future of Precision Medicine. Below is an excerpt from the article:

(more…)

Precision for Medicine’s acquisition of Precision Health Economics is covered in PharmaVoice.

Precision for Medicine’s Larry Blandford quoted in today’s Wall Street Journal article: “New Push Ties Cost of Drugs to How Well They Work.” The effort is part of a growing push for so-called pay-for-performance deals amid complaints about the rising price of medications, some of which cost more than $100,000 per patient a year.